অস্ট্রেলিয়া - ইংরেজি - Department of Health (Therapeutic Goods Administration)

blackmores ltd - ascorbic acid,biotin,calcium pantothenate,cyanocobalamin,folic acid,heavy magnesium oxide,nicotinamide,pyridoxine hydrochloride,riboflavine,thiamine nitrate,withania somnifera,zinc amino acid chelate -

অস্ট্রেলিয়া - ইংরেজি - Department of Health (Therapeutic Goods Administration)

catalent australia pty ltd - ascorbic acid,biotin,calcium pantothenate,choline bitartrate,cyanocobalamin,folic acid,heavy magnesium oxide,inositol,nicotinamide,pyridoxine hydrochloride,riboflavine,thiamine nitrate,zinc sulfate monohydrate -

মাল্যাশিয়া - ইংরেজি - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

procter & gamble (malaysia ) sdn.bhd. - zinc oxide; cyanocobalamin; biotin; calcium pantothenate; cholecalciferol; folic acid; potassium iodide; potassium chloride; pyridoxine hydrochloride; magnesium oxide,heavy; riboflavine; calcium ascorbate; nicotinamide; thiamine nitrate; manganese sulphate monohydrate; bifidobacterium bifidum; bifidobacterium longum; alpha tocopherol acetate; synthetic vitamin a concentrated; chromium chloride hexahydrate; sodium molybdate dihydrate; ferrous sulphate hydrate; sodium selenate 1%; tricalcium phosphate anhydro -

মার্কিন যুক্তরাষ্ট্র - ইংরেজি - NLM (National Library of Medicine)

mylan pharmaceuticals inc. - chlordiazepoxide (unii: 6rz6xez3cr) (chlordiazepoxide - unii:6rz6xez3cr), amitriptyline hydrochloride (unii: 26lud4jo9k) (amitriptyline - unii:1806d8d52k) - chlordiazepoxide 5 mg - chlordiazepoxide and amitriptyline hydrochloride tablets are indicated for the treatment of patients with moderate to severe depression associated with moderate to severe anxiety. the therapeutic response to chlordiazepoxide and amitriptyline hydrochloride tablets occurs earlier and with fewer treatment failures than when either amitriptyline or chlordiazepoxide is used alone. symptoms likely to respond in the first week of treatment include: insomnia, feelings of guilt or worthlessness, agitation, psychic and somatic anxiety, suicidal ideation and anorexia. chlordiazepoxide and amitriptyline hydrochloride tablets are contraindicated in patients with hypersensitivity to either benzodiazepines or tricyclic antidepressants. it should not be given concomitantly with a monoamine oxidase inhibitor. hyperpyretic crises, severe convulsions and deaths have occurred in patients receiving a tricyclic antidepressant and a monoamine oxidase inhibitor simultaneously. when it is desired to replace a monoamine oxidase inhibitor with chlordiazepoxide and amitriptyline hydrochloride tablets, a minimum of 14 days should be allowed to elapse after the former is discontinued. chlordiazepoxide and amitriptyline hydrochloride tablets should then be initiated cautiously with gradual increase in dosage until optimum response is achieved. this drug is contraindicated during the acute recovery phase following myocardial infarction. chlordiazepoxide and amitriptyline hydrochloride tablets contain chlordiazepoxide, a schedule iv controlled substance. chlordiazepoxide and amitriptyline hydrochloride tablets are a benzodiazepine and a cns depressant with a potential for abuse and addiction. abuse is the intentional, non-therapeutic use of a drug, even once, for its desirable psychological or physiological effects. misuse is the intentional use, for therapeutic purposes, of a drug by an individual in a way other than prescribed by a health care provider or for whom it was not prescribed. drug addiction is a cluster of behavioral, cognitive, and physiological phenomena that may include a strong desire to take the drug, difficulties in controlling drug use (e.g., continuing drug use despite harmful consequences, giving a higher priority to drug use than other activities and obligations), and possible tolerance or physical dependence. even taking benzodiazepines as prescribed may put patients at risk for abuse and misuse of their medication. abuse and misuse of benzodiazepines may lead to addiction. abuse and misuse of benzodiazepines often (but not always) involve the use of doses greater than the maximum recommended dosage and commonly involve concomitant use of other medications, alcohol, and/or illicit substances, which is associated with an increased frequency of serious adverse outcomes, including respiratory depression, overdose, or death. benzodiazepines are often sought by individuals who abuse drugs and other substances, and by individuals with addictive disorders (see warnings: abuse, misuse, and addiction). the following adverse reactions have occurred with benzodiazepine abuse and/or misuse: abdominal pain, amnesia, anorexia, anxiety, aggression, ataxia, blurred vision, confusion, depression, disinhibition, disorientation, dizziness, euphoria, impaired concentration and memory, indigestion, irritability, muscle pain, slurred speech, tremors, and vertigo. the following severe adverse reactions have occurred with benzodiazepine abuse and/or misuse: delirium, paranoia, suicidal ideation and behavior, seizures, coma, breathing difficulty, and death. death is more often associated with polysubstance use (especially benzodiazepines with other cns depressants such as opioids and alcohol). chlordiazepoxide and amitriptyline hydrochloride tablets may produce physical dependence from continued therapy. physical dependence is a state that develops as a result of physiological adaptation in response to repeated drug use, manifested by withdrawal signs and symptoms after abrupt discontinuation or a significant dose reduction of a drug. abrupt discontinuation or rapid dosage reduction of benzodiazepines or administration of flumazenil, a benzodiazepine antagonist, may precipitate acute withdrawal reactions, including seizures, which can be life-threatening. patients at an increased risk of withdrawal adverse reactions after benzodiazepine discontinuation or rapid dosage reduction include those who take higher dosages (i.e., higher and/or more frequent doses) and those who have had longer durations of use (see warnings: dependence and withdrawal reactions). to reduce the risk of withdrawal reactions, use a gradual taper to discontinue chlordiazepoxide and amitriptyline hydrochloride tablets or reduce the dosage (see dosage and administration: discontinuation or dosage reduction of chlordiazepoxide and amitriptyline hydrochloride tablets and warnings: dependence and withdrawal reactions). acute withdrawal signs and symptoms associated with benzodiazepines have included abnormal involuntary movements, anxiety, blurred vision, depersonalization, depression, derealization, dizziness, fatigue, gastrointestinal adverse reactions (e.g., nausea, vomiting, diarrhea, weight loss, decreased appetite), headache, hyperacusis, hypertension, irritability, insomnia, memory impairment, muscle pain and stiffness, panic attacks, photophobia, restlessness, tachycardia, and tremor. more severe acute withdrawal signs and symptoms, including life-threatening reactions, have included catatonia, convulsions, delirium tremens, depression, hallucinations, mania, psychosis, seizures, and suicidality. protracted withdrawal syndrome associated with benzodiazepines is characterized by anxiety, cognitive impairment, depression, insomnia, formication, motor symptoms (e.g., weakness, tremor, muscle twitches), paresthesia, and tinnitus that persists beyond 4 to 6 weeks after initial benzodiazepine withdrawal. protracted withdrawal symptoms may last weeks to more than 12 months. as a result, there may be difficulty in differentiating withdrawal symptoms from potential re-emergence or continuation of symptoms for which the benzodiazepine was being used. tolerance to chlordiazepoxide and amitriptyline hydrochloride tablets may develop from continued therapy. tolerance is a physiological state characterized by a reduced response to a drug after repeated administration (i.e., a higher dose of a drug is required to produce the same effect that was once obtained at a lower dose). tolerance to the therapeutic effect of chlordiazepoxide and amitriptyline hydrochloride tablets may develop; however, little tolerance develops to the amnestic reactions and other cognitive impairments caused by benzodiazepines.

অস্ট্রেলিয়া - ইংরেজি - Department of Health (Therapeutic Goods Administration)

pharmacare laboratories pty ltd - magnesium amino acid chelate, quantity: 10 mg (equivalent: magnesium, qty 2 mg); magnesium citrate, quantity: 10 mg (equivalent: magnesium, qty 1.55 mg); pyridoxine hydrochloride, quantity: 50 mg (equivalent: pyridoxine, qty 41.1 mg); magnesium phosphate pentahydrate, quantity: 80 mg (equivalent: magnesium, qty 16.5 mg); heavy magnesium oxide, quantity: 500 mg (equivalent: magnesium, qty 301.6 mg); manganese amino acid chelate, quantity: 40 mg (equivalent: manganese, qty 4 mg); colecalciferol, quantity: 0.0 - tablet, film coated - excipient ingredients: magnesium stearate; povidone; macrogol 400; carnauba wax; hypromellose; colloidal anhydrous silica; crospovidone; calcium hydrogen phosphate dihydrate; microcrystalline cellulose; maize starch; acacia; silicon dioxide; dl-alpha-tocopherol; sucrose; medium chain triglycerides; titanium dioxide - antioxidant/reduce free radicals formed in the body ; helps reduce/decrease free radical damage to body cells ; maintain/support energy levels ; maintain/support energy production ; maintain/support general health and wellbeing ; maintain/support bone health ; help maintain/support bone mineralisation ; maintain/support cardiovascular system health ; maintain/support healthy cardiovascular system function ; decrease/reduce/relieve muscle cramps ; helps decrease/reduce/relieve mild muscle spasms/twitches ; maintain/support healthy muscle contraction function ; maintain/support muscle health ; maintain/support muscle function ; decrease/reduce/relieve muscle pain/ache/soreness ; decrease/reduce/relieve muscle tension/stiffness ; maintain/support (state vitamin/mineral/nutrient) levels in the body ; helps prevent dietary (state vitamin/mineral/nutrient) deficiency ; aid/assist/helps metabolism of (state vitamin/mineral/nutrient) ; support healthy stress response in the body

অস্ট্রেলিয়া - ইংরেজি - Department of Health (Therapeutic Goods Administration)

blackmores ltd - magnesium amino acid chelate, quantity: 75 mg (equivalent: magnesium, qty 15 mg); heavy magnesium oxide, quantity: 423.22 mg (equivalent: magnesium, qty 245 mg); chromium picolinate, quantity: 402.25 microgram (equivalent: chromium, qty 50 microgram); manganese amino acid chelate, quantity: 40 mg (equivalent: manganese, qty 4 mg); calcium ascorbate dihydrate, quantity: 60.52 mg (equivalent: ascorbic acid, qty 50 mg; equivalent: calcium, qty 5.69 mg); pyridoxine hydrochloride, quantity: 60.78 mg (equivalent: pyridoxine, qty 50 mg); magnesium citrate, quantity: 291.26 mg (equivalent: magnesium, qty 45 mg); colecalciferol, quantity: 0.0025 mg - tablet, film coated - excipient ingredients: colloidal anhydrous silica; carnauba wax; tartaric acid; microcrystalline cellulose; calcium hydrogen phosphate dihydrate; maize starch; soy polysaccharide; titanium dioxide; macrogol 8000; hypromellose; croscarmellose sodium; magnesium stearate; acacia; silicon dioxide; dl-alpha-tocopherol; sucrose; medium chain triglycerides - maintain/support energy levels ; relieve weariness/tiredness/fatigue/feeling of weakness ; maintain/support body electrolyte balance ; maintain/support general health and wellbeing ; maintain/support cardiovascular system health ; decrease/reduce/relieve muscle cramps ; helps decrease/reduce/relieve mild muscle spasms/twitches ; maintain/support muscle health ; decrease/reduce/relieve muscle tension/stiffness ; maintain/support muscle performance/endurance/stamina ; aid/assist/helps glucose/sugar/carbohydrate metabolism ; maintain/support nervous system health ; maintain/support nervous system function

অস্ট্রেলিয়া - ইংরেজি - Department of Health (Therapeutic Goods Administration)

vitaminhaus pty ltd - betacarotene,biotin,calcium ascorbate,calcium carbonate,calcium pantothenate,choline bitartrate,colecalciferol,ferrous sulfate,folic acid,heavy magnesium oxide,pyridoxine hydrochloride,riboflavin,silicon dioxide,thiamine nitrate,zinc amino acid chelate -

অস্ট্রেলিয়া - ইংরেজি - Department of Health (Therapeutic Goods Administration)

reckon health care pty ltd - ascorbic acid,biotin,borago officinalis,calcium carbonate,calcium pantothenate,chromium picolinate,colecalciferol,cyanocobalamin,citrus bioflavonoids extract,d-alpha-tocopherol,evening primrose oil,folic acid,heavy magnesium oxide,nicotinamide,phytomenadione,pyridoxine hydrochloride,riboflavine,selenomethionine,thiamine nitrate -

অস্ট্রেলিয়া - ইংরেজি - Department of Health (Therapeutic Goods Administration)

reckon health care pty ltd - ascorbic acid,betacarotene,biotin,calcium carbonate,calcium pantothenate,chromium picolinate,colecalciferol,concentrated fish omega-3 triglycerides,cyanocobalamin,d-alpha-tocopherol,ferrous fumarate,folic acid,heavy magnesium oxide,nicotinamide,phytomenadione,pyridoxine hydrochloride,riboflavine,selenomethionine,thiamine nitrate,zinc oxide -

অস্ট্রেলিয়া - ইংরেজি - Department of Health (Therapeutic Goods Administration)

catalent australia pty ltd - calcium carbonate,calcium pantothenate,colecalciferol,cupric sulfate,cyanocobalamin,heavy magnesium oxide,manganese sulfate monohydrate,pyridoxine hydrochloride,thiamine hydrochloride,zinc sulfate monohydrate -